Warhound
Gene-edited and cloned working dogs for military, police and first responders
The founders
BL
The company
Warhound breeds working dogs for military, law enforcement and first-responder use, applying genomics, gene editing and cloning to select for health, longevity, temperament and trainability. The company uses technology licensed from Colossal Biosciences, which holds equity in the business.
Demand for reliable K9s across defence and public safety is persistent, yet breeding for performance remains slow and imprecise; Warhound is betting that genomics and cloning can tighten the odds on which dogs make the grade.
The concept was developed by Colossal co-founder Ben Lamm and Anduril founder Palmer Luckey, with Lamm on the board and Luckey holding no equity. It launched in October 2026 with CEO David Spirk, a former US Marine and former Chief Data Officer at the US Department of Defense and USSOCOM, at the helm.
Spirk brings direct defence and data leadership from the DoD and USSOCOM, while the Colossal licence gives Warhound a technology base in gene editing and cloning rather than a standing start.
Who else is building in this space
Companies working on the same thing, at every stage.
Unicorn
Provides a real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease
Unicorn
Automated cell programming and biological engineering platform.
Unicorn
Developing a new generation of nanopore-based electronic systems for analysis of single molecules
Unicorn
Technology company unlocking the power of biology
Unicorn
Focused on creating and delivering engineered cells as medicines for patients
Unicorn
Developing step-change products to transform the food system through positive change
Thousands more founded every month.
Dealroom tracks new companies as they appear — founders, funding and signals, over the API or in the platform.